Alvotech Nears U.S. Approval for Biosimilar MedicinesIn a significant development for Alvotech (NASDAQ: NASDAQ:ALVO ), a global biotech company specializing in biosimilar medicines, the conclusion of the U.S. Food and Drug Administration (FDA) reinspection of its facility in Iceland has brought the company one step closer to achieving regulatory appr